BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 29511141)

  • 1. Animal models for filovirus infections.
    Siragam V; Wong G; Qiu XG
    Zool Res; 2018 Jan; 39(1):15-24. PubMed ID: 29511141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
    Stock I
    Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Animal Models for Evaluating Filovirus Countermeasures.
    Banadyga L; Wong G; Qiu X
    ACS Infect Dis; 2018 May; 4(5):673-685. PubMed ID: 29457711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
    Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
    J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Sudan Ebolavirus infection in ferrets.
    Kroeker A; He S; de La Vega MA; Wong G; Embury-Hyatt C; Qiu X
    Oncotarget; 2017 Jul; 8(28):46262-46272. PubMed ID: 28545034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models for filovirus infections.
    Bradfute SB; Warfield KL; Bray M
    Viruses; 2012 Sep; 4(9):1477-508. PubMed ID: 23170168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad and Temperature Independent Replication Potential of Filoviruses on Cells Derived From Old and New World Bat Species.
    Miller MR; McMinn RJ; Misra V; Schountz T; Müller MA; Kurth A; Munster VJ
    J Infect Dis; 2016 Oct; 214(suppl 3):S297-S302. PubMed ID: 27354372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.
    Mire CE; Geisbert JB; Versteeg KM; Mamaeva N; Agans KN; Geisbert TW; Connor JH
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S384-8. PubMed ID: 25957964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
    Geisbert TW; Strong JE; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small animal models of filovirus disease: recent advances and future directions.
    Cross RW; Fenton KA; Geisbert TW
    Expert Opin Drug Discov; 2018 Nov; 13(11):1027-1040. PubMed ID: 30269599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marburg and Ebola virus infections in laboratory non-human primates: a literature review.
    Schou S; Hansen AK
    Comp Med; 2000 Apr; 50(2):108-23. PubMed ID: 10857001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.
    Lever MS; Piercy TJ; Steward JA; Eastaugh L; Smither SJ; Taylor C; Salguero FJ; Phillpotts RJ
    J Med Microbiol; 2012 Jan; 61(Pt 1):8-15. PubMed ID: 21852521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.
    Banadyga L; Dolan MA; Ebihara H
    J Mol Biol; 2016 Aug; 428(17):3449-66. PubMed ID: 27189922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines.
    Marzi A; Kercher L; Marceau J; York A; Callsion J; Gardner DJ; Geisbert TW; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S404-9. PubMed ID: 26022440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
    Warren TK; Wells J; Panchal RG; Stuthman KS; Garza NL; Van Tongeren SA; Dong L; Retterer CJ; Eaton BP; Pegoraro G; Honnold S; Bantia S; Kotian P; Chen X; Taubenheim BR; Welch LS; Minning DM; Babu YS; Sheridan WP; Bavari S
    Nature; 2014 Apr; 508(7496):402-5. PubMed ID: 24590073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
    Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
    BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.
    Comer JE; Escaffre O; Neef N; Brasel T; Juelich TL; Smith JK; Smith J; Kalveram B; Perez DD; Massey S; Zhang L; Freiberg AN
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30717492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, validation and clinical evaluation of a broad-range pan-filovirus RT-qPCR.
    Jääskeläinen AJ; Sironen T; Diagne CT; Diagne MM; Faye M; Faye O; Faye O; Hewson R; Mölsä M; Weidmann MW; Watson R; Sall AA; Vapalahti O
    J Clin Virol; 2019 May; 114():26-31. PubMed ID: 30904708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid molecular strategy for filovirus detection and characterization.
    Zhai J; Palacios G; Towner JS; Jabado O; Kapoor V; Venter M; Grolla A; Briese T; Paweska J; Swanepoel R; Feldmann H; Nichol ST; Lipkin WI
    J Clin Microbiol; 2007 Jan; 45(1):224-6. PubMed ID: 17079496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.